Treatment of Ocular Dermatitis
The first-line treatment for ocular dermatitis is tacrolimus 0.1% ointment applied once daily to the external eyelids and lid margins for 2-4 weeks, with preservative-free ocular lubricants as adjunctive therapy. 1
Treatment Algorithm Based on Age and Severity
For Adults:
Mild Disease
First-line treatment:
If inadequate response:
If still inadequate:
Moderate to Severe Disease
Initial treatment:
If inadequate response:
For treatment-resistant cases:
For Children:
Under 7 years:
- Refer to ophthalmology regardless of severity due to risk to neuro-ocular development 2
- Preservative-free ocular lubricants as initial therapy while awaiting ophthalmology assessment 2
- Tacrolimus 0.03% (not 0.1%) should be used if recommended by ophthalmologist 1
- Warm compress regimens not recommended 2
7-17 years:
- Mild to moderate: Same as adults, but refer to ophthalmology if no response to lubricants or antihistamine drops 2
- Severe: Urgent ophthalmology referral (within 4 weeks) 2
- Tacrolimus use should follow ophthalmology advice 2
Important Considerations
Topical Corticosteroids
- Use the least potent preparation required to control symptoms 1
- Apply no more than twice daily 1
- Short-term use only (maximum 8 weeks) 2
- Risk of increased intraocular pressure and cataracts with long-term use 1
- Hydrocortisone can be used for children over 2 years of age, no more than 3-4 times daily 3
Referral Indications
- Children under 7 years: All cases 2
- Children 7-17 years: Non-response to initial therapy or severe disease 2
- Adults: Severe disease or non-response to topical treatment and lid hygiene 2
- Progressive loss of visual acuity 2
- Suspected bacterial or viral infections 1
Avoiding Triggers
- Discontinue suspected allergens (common culprits: eye drops, creams/lotions, cosmetics) 4
- Avoid wool clothing, extreme temperatures, harsh soaps 1
- Use preservative-free formulations due to increased risk of allergic contact dermatitis 2, 1
Special Considerations for Dupilumab-Related Ocular Surface Disorders (DROSD)
If ocular dermatitis is related to dupilumab therapy:
- Consider dose reduction in patients with good skin control 2
- Consider withdrawal of dupilumab if there is:
- Progressive loss of visual acuity unresponsive to treatment
- Need for prolonged ocular topical corticosteroid therapy (>8 weeks)
- Significant impact on quality of life 2
Common Pitfalls to Avoid
- Using preserved eye drops or ointments, which can exacerbate allergic contact dermatitis 2, 1
- Prolonged use of topical corticosteroids around the eyes 1
- Using hot flannels for warm compresses (risk of scalding) 2
- Failing to identify and eliminate causative agents 4
- Delaying ophthalmology referral for children under 7 years 2
- Overlooking bacterial or viral infections that may require specific treatment 2
- Not considering patch testing in treatment-resistant cases 2, 5
By following this structured approach based on age and severity, most cases of ocular dermatitis can be effectively managed with good outcomes for vision and quality of life.